# Semalytix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/semalytix

- Industry: Healthcare IT
- Headquarters: Bielefeld, Germany
- Website: www.semalytix.com
- Total disclosed funding: $4.9M
- Latest round: Series A (Jan 3, 2023)
- Investors on record: 6

## About

Semalytix GmbH specializes in harnessing generative AI and natural language processing to convert patient and physician experience data into actionable insights, thereby enhancing decision-making in healthcare and pharmaceuticals.Founded in 2015 and headquartered in Germany, Semalytix GmbH focuses on transforming healthcare data through innovative AI solutions. The company has not undergone any known pivots or structural changes since its inception. Founded by Janik Jaskolski, Matthias Hartung, and Philipp Cimiano, who possess backgrounds in AI and healthcare technologies, Semalytix has successfully completed 7 deals, with the most recent funding round occurring on January 3, 2023. This Series A round raised EUR 2.000 mn, led by NRW Bank, which brought the total amount raised to EUR 2.000 mn and positioned the company with a current valuation of EUR 20.135 mn.Semalytix offers a comprehensive suite of products focused on leveraging generative AI and natural language processing to transform patient and physician experience data into actionable insights. Their core offerings include PatientGPT, Patient Journeys, Pharos Suite, and PatientX Datastream, all designed to address critical functions in the pharmaceutical and healthcare sectors. These products facilitate the analysis of millions of real-world patient experiences across various therapy areas, helping clients understand patient needs, treatment experiences, and quality-of-life impacts. Semalytix serves a diverse client base that includes pharmaceutical companies, healthcare providers, and researchers, primarily in Europe and North America, enabling them to make data-driven decisions in clinical development and market strategies.Semalytix generates revenue through a subscription-based model, where clients pay for access to its advanced data analytics platforms and insights. Transactions typically occur as part of long-term partnerships with pharmaceutical companies and healthcare organizations, who utilize the data for research, clinical trial design, and market analysis. Customers engage with the company's offerings through tailored packages that fit their specific needs, allowing for scalable access to insights from their extensive patient experience data archive. While specific pricing details for individual products are not disclosed, the structure emphasizes value through enhanced research efficiency and evidence generation, contributing to a more informed approach to drug development and patient care.In January 2023, Semalytix GmbH raised EUR 2.000 mn in Series A funding led by NRW Bank, aimed at expanding its product offerings and market presence. The company plans to launch new products that enhance data analytics capabilities, targeting the European and North American markets for expansion by mid-2024. The new funding will be strategically utilized to support product development and facilitate entry into additional healthcare markets, enhancing their capacity to deliver insights that drive pharmaceutical innovations.

## Funding rounds

- Series A, Jan 3, 2023 — NRW Bank, b2venture, Hamba Investments, Centurio Ventures GmbH
- Series A, Jun 2, 2022 — NRW Bank, b2venture, Hamba Investments
- Series A, Jan 21, 2022 — NRW Bank, b2venture, Fly Ventures, Hamba Investments, Centurio Ventures GmbH
- Series A, Aug 13, 2021 — NRW Bank, b2venture, Fly Ventures, Karma Ventures, Centurio Ventures GmbH
- Series A, Jul 21, 2020, $4.9M — b2venture, Fly Ventures, Karma Ventures
- Seed, Aug 1, 2018 — Fly Ventures

## Investors

- Fly Ventures (https://capitalatlas.ai/funds/fly-ventures) — Seed, Series A
- b2venture (https://capitalatlas.ai/funds/b2venture) — Series A
- Karma Ventures (https://capitalatlas.ai/funds/karma-ventures) — Series A
- NRW Bank — Series A
- Centurio Ventures GmbH — Series A
- Hamba Investments (https://capitalatlas.ai/funds/hamba-investments) — Series A